Pharmacogenetics- and pharmacogenomics-based rational clinical trial designs in oncology

Personalized Medicine
Rui Qin, Manish Kohli

Abstract

The rapid evolution of molecular technologies that can identify genetic markers and lead to dissecting the inherent variance of individual cancer biology has had a tangible impact on trial designs in oncology. Rational trial designs based on molecular marker expression coupled with drug-marker interactions have started to be adopted, challenging the previous paradigms of morphology-based, single-arm efficacy studies. This review summarizes novel trials being developed based on molecular predictive factor therapeutics and the potential impact these novel trial designs will have on the practice of oncology in future. A variety of clinical trial designs based on tumor and drug-host genetic interactions are discussed and the example of advanced prostate cancer is used to illustrate the changing landscape of clinical trial designs in cancer.

References

Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Oct 8, 1998·The New England Journal of Medicine·M A EisenbergerB A Lowe
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary L RosnerMark J Ratain
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard Simon, Aboubakar Maitournam
Nov 20, 2004·Statistics in Medicine·A Maitournam, R Simon
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J SargentLaurence Collette
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Boris Freidlin, Richard Simon
Sep 5, 2006·Annual Review of Genomics and Human Genetics·Richard M Weinshilboum, Liewei Wang
Feb 3, 2007·Statistics in Medicine·Yang Song, George Y H Chi
Jun 29, 2007·Journal of the National Cancer Institute·Wenyu JiangRichard Simon
Aug 11, 2007·Pharmaceutical Statistics·Sue-Jane WangH M James Hung
Apr 9, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C N A M OldenhuisE G E de Vries
Jun 19, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Xian ZhouJ Jack Lee
Apr 23, 2009·Journal of Biopharmaceutical Statistics·Sumithra J Mandrekar, Daniel J Sargent
May 15, 2009·Clinical Pharmacology and Therapeutics·A D BarkerL J Esserman
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhardt AttardJohann S de Bono
Jan 1, 2010·Mayo Clinic Proceedings·Manish Kohli, Donald J Tindall
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Boris FreidlinRichard Simon
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janet E DanceyUNKNOWN Biomarkers Task Force of the NCI Investigational Drug Steering Committee
Jun 24, 2010·Clinical Trials : Journal of the Society for Clinical Trials·J Jack Lee Suyu Liu
Jun 24, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Jens C EickhoffJason R Gee
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Aug 6, 2010·Cancer Treatment Reviews·Michael J DuffyJohn Crown
Aug 6, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Aiyi LiuVivian W Yuan
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Sep 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthias SimonMarc Sanson
Jun 15, 1946·Journal of the American Medical Association·C HUGGINS
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L Korn, Boris Freidlin
Jan 15, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Robin K KelleyAlan P Venook
Apr 8, 2011·The New England Journal of Medicine·Jia-Ming Wang, Shih-Chieh Chang
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jul 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christian RuizMichael T Barrett
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Akash KumarJay Shendure
Jul 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·J Jack LeeGuosheng Yin
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C SmithMaha Hussain

❮ Previous
Next ❯

Citations

Feb 5, 2015·Clinical Trials : Journal of the Society for Clinical Trials·J Jack Lee
May 27, 2014·Expert Review of Molecular Diagnostics·Paul Christiaan BankHenk-Jan Guchelaar

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
biopsies
exome sequencing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of the Academy of Medicine, Singapore
Boon Cher GohSoo Chin Lee
Pharmacogenomics
Rianne M F van SchieAnke Hilse Maitland-van der Zee
JAAPA : Official Journal of the American Academy of Physician Assistants
Lawrence Carey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Kouros Owzar
© 2022 Meta ULC. All rights reserved